8 November 2023 - Another underwhelming agenda; yet again there is no application for a cancer medicine. ...
6 November 2023 - The EMA has published a draft agenda for this week's CHMP meeting. ...
31 October 2023 - - The MSAC Secretariat has published a revised ist of applications scheduled to be considered by ...
30 October 2023 - Independent appraisal committee voted that across all patient sub-populations, arsa-cel demonstrated a net health benefit when ...
30 October 2023 - The agenda for this week's November 2023 meeting has been updated. ...
27 October 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2023 PBAC ...
18 October 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC ...
9 October 2023 - The EMA has published a draft agenda for this week's CHMP meeting. ...
27 September 2023 - The agenda for the November 2023 meeting has been updated yet again. ...
25 September 2023 - Registration now open for 5 October “Early Insights” webinar. ...
19 September 2023 - Fundamental revision of the cost benefit assessment and addition of the concept of application-accompanying data collection. ...
14 September 2023 - Using weighted analyses across all patient subpopulations, atidarsagene autotemcel would achieve common thresholds for cost effectiveness if priced ...
14 September 2023 - The Department has today published version 4 of the agenda for the November 2023 PBAC meeting. ...
11 September 2023 - The EMA has published a draft agenda for this week's CHMP meeting. ...
6 September 2023 - The third version of the agenda for the next PBAC meeting is now available. ...